Matches in Wikidata for { <http://www.wikidata.org/entity/Q91806170> ?p ?o ?g. }
- Q91806170 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q91806170 description "im Juli 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91806170 description "scientific article published on 08 July 2019" @default.
- Q91806170 description "wetenschappelijk artikel" @default.
- Q91806170 description "наукова стаття, опублікована 8 липня 2019" @default.
- Q91806170 name "Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study" @default.
- Q91806170 name "Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study" @default.
- Q91806170 type Item @default.
- Q91806170 label "Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study" @default.
- Q91806170 label "Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study" @default.
- Q91806170 prefLabel "Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study" @default.
- Q91806170 prefLabel "Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study" @default.
- Q91806170 P1433 Q91806170-B8C16FFD-9B4B-4562-87CA-6CE86E86314C @default.
- Q91806170 P1476 Q91806170-A734437F-E8F6-46DC-9326-463AE19ABE2C @default.
- Q91806170 P2093 Q91806170-02819805-54B1-46FD-93B6-37D7B0D41D73 @default.
- Q91806170 P2093 Q91806170-10E99A2A-D531-448B-90F8-CAD04BF8C4CE @default.
- Q91806170 P2093 Q91806170-23FA62CB-4254-423A-9430-FFADEFE26C0B @default.
- Q91806170 P2093 Q91806170-2B557B3B-DDED-4472-88F1-AC03EAAE2096 @default.
- Q91806170 P2093 Q91806170-31AFB813-1C15-4FBF-92D4-FF3F4BFF04D4 @default.
- Q91806170 P2093 Q91806170-3637FCAA-D7C3-4470-B524-F10CEAED2F70 @default.
- Q91806170 P2093 Q91806170-67E5C21D-ED4E-4481-98A4-73E097B7109A @default.
- Q91806170 P2093 Q91806170-6A01A917-6ED0-452E-97DB-BF0CB6F92180 @default.
- Q91806170 P2093 Q91806170-6E63BA1E-A456-4C0A-92CF-1FFE2C287410 @default.
- Q91806170 P2093 Q91806170-8921E898-8673-4534-B77B-2490C56EACAF @default.
- Q91806170 P2093 Q91806170-8F57A402-F58B-488A-9EB0-6B6610E58CD3 @default.
- Q91806170 P2093 Q91806170-A41F4B49-C890-456A-A1BA-0A412016BB33 @default.
- Q91806170 P2093 Q91806170-AFEE27C8-71D3-47A6-8D87-A61176686D60 @default.
- Q91806170 P2093 Q91806170-DBAE3AD1-F6A5-4AD4-B5B3-46ECF0856448 @default.
- Q91806170 P2093 Q91806170-DF60AB46-150E-4A1A-8E8A-442BC8D16C98 @default.
- Q91806170 P2093 Q91806170-E24FF1FB-369C-4245-A90D-701BF0E9D2CC @default.
- Q91806170 P2093 Q91806170-EE533077-4298-423E-B2F6-157F171622EF @default.
- Q91806170 P2093 Q91806170-EF8E4726-D55E-48EA-AA71-DF743FBD6F2B @default.
- Q91806170 P2093 Q91806170-FF82F711-88C4-4A69-8F3D-746869C0A3B1 @default.
- Q91806170 P2860 Q91806170-074FC9F3-CFA5-4AC1-9436-10E373A8AF0B @default.
- Q91806170 P2860 Q91806170-0EEFD2F0-14E6-461F-818A-4452D0554070 @default.
- Q91806170 P2860 Q91806170-13B1644F-DDE3-4522-91B7-3608E68EFF12 @default.
- Q91806170 P2860 Q91806170-19A58F69-153E-4431-AFF6-D7605BAD49F0 @default.
- Q91806170 P2860 Q91806170-1DE668F8-6D8E-4C98-80FD-5936723E7658 @default.
- Q91806170 P2860 Q91806170-22102CB3-2196-4410-AD1B-991EB0368D24 @default.
- Q91806170 P2860 Q91806170-307111AE-AA8C-4BFF-A393-E2AE387D3841 @default.
- Q91806170 P2860 Q91806170-32691C10-3760-4CD4-BEA1-316E87D611D9 @default.
- Q91806170 P2860 Q91806170-35053326-C23A-40BB-89AE-3F01435DC68A @default.
- Q91806170 P2860 Q91806170-508D5484-9123-4C85-9914-2F1C5F0C97FB @default.
- Q91806170 P2860 Q91806170-5340A546-2493-4322-8ADE-84B185A2634C @default.
- Q91806170 P2860 Q91806170-5B1AB61A-3937-47EE-B8DB-F0361FA7AEEA @default.
- Q91806170 P2860 Q91806170-731A8DB2-EBD6-4F1E-9838-2722D15C3151 @default.
- Q91806170 P2860 Q91806170-7A0C8EE5-7975-4CFB-847B-59146DBEBC0B @default.
- Q91806170 P2860 Q91806170-87882878-C9AD-4DB6-968E-D19BAFBF0644 @default.
- Q91806170 P2860 Q91806170-883CFEDF-6ADA-4591-B035-ECE8CD7754D0 @default.
- Q91806170 P2860 Q91806170-913C8F78-62BB-4784-98AA-D56650F9878E @default.
- Q91806170 P2860 Q91806170-9C9A8663-8FC7-42E5-8DF1-0B7C5423023E @default.
- Q91806170 P2860 Q91806170-9FEAA739-08CB-476E-B2CD-08DB2908A56B @default.
- Q91806170 P2860 Q91806170-B8968C79-95F8-48D9-BE76-D3E01AD2A2FE @default.
- Q91806170 P2860 Q91806170-B98EF735-7519-489A-B726-16776B774012 @default.
- Q91806170 P2860 Q91806170-BF6E1E2D-C2F0-43B2-9F2B-7876E6B2799A @default.
- Q91806170 P2860 Q91806170-C8512241-44BD-4791-A7D2-F4F69371C4E3 @default.
- Q91806170 P2860 Q91806170-DC4AB9FB-AA3F-450F-83AD-B2A3AC058785 @default.
- Q91806170 P2860 Q91806170-E9E81679-B980-4EDE-A390-B18A39BD579C @default.
- Q91806170 P304 Q91806170-3B99ED1A-A0F0-4603-9E03-70437E61F0C1 @default.
- Q91806170 P31 Q91806170-43B9CFA1-90CE-49CF-8371-43584A424D88 @default.
- Q91806170 P356 Q91806170-38B71D58-1F04-4BF0-8B6B-EC7F99FD2408 @default.
- Q91806170 P433 Q91806170-63A5C362-CC51-4270-8275-A55518CB8BEF @default.
- Q91806170 P478 Q91806170-B20E90DE-E3F4-4B98-8F2B-06E223D65BF7 @default.
- Q91806170 P50 Q91806170-A81F925D-C293-4C81-B902-8352193AA097 @default.
- Q91806170 P577 Q91806170-3B148332-E0A4-4BA4-B81C-0F2364246392 @default.
- Q91806170 P698 Q91806170-D35A222F-D1AD-4B44-AB59-7C8311A9068E @default.
- Q91806170 P921 Q91806170-610FB58E-E0E1-4143-A527-1EA42744513B @default.
- Q91806170 P356 S2352-3026(19)30089-4 @default.
- Q91806170 P698 31296423 @default.
- Q91806170 P1433 Q26840042 @default.
- Q91806170 P1476 "Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study" @default.
- Q91806170 P2093 "Christophe Bonnet" @default.
- Q91806170 P2093 "Christophe Fruchart" @default.
- Q91806170 P2093 "Corinne Haioun" @default.
- Q91806170 P2093 "Danielle Canioni" @default.
- Q91806170 P2093 "Emmanuelle Nicolas-Virelizier" @default.
- Q91806170 P2093 "Fontanet Bijou" @default.
- Q91806170 P2093 "Franck Morschhauser" @default.
- Q91806170 P2093 "Gilles A Salles" @default.
- Q91806170 P2093 "Guillaume Cartron" @default.
- Q91806170 P2093 "Hervé Tilly" @default.
- Q91806170 P2093 "Ka Lung Wu" @default.
- Q91806170 P2093 "Koen Van Eygen" @default.
- Q91806170 P2093 "Pierre Feugier" @default.
- Q91806170 P2093 "Reda Bouabdallah" @default.
- Q91806170 P2093 "Roch Houot" @default.
- Q91806170 P2093 "Sarah Bailly" @default.
- Q91806170 P2093 "Steven Le Gouill" @default.
- Q91806170 P2093 "Sylvia Snauwaert" @default.
- Q91806170 P2093 "Véronique Meignin" @default.
- Q91806170 P2860 Q28241808 @default.
- Q91806170 P2860 Q33406742 @default.
- Q91806170 P2860 Q33433426 @default.
- Q91806170 P2860 Q33690142 @default.
- Q91806170 P2860 Q33773306 @default.
- Q91806170 P2860 Q33896738 @default.
- Q91806170 P2860 Q36211619 @default.
- Q91806170 P2860 Q36934350 @default.
- Q91806170 P2860 Q37380415 @default.
- Q91806170 P2860 Q38474278 @default.